We collaborate with laboratories and sponsors in the development of oncology clinical trials, combining local expertise with international standards.
We work alongside global leaders in the pharmaceutical industry on oncology clinical trials.
LC Investigación develops and manages oncology clinical studies in collaboration with the pharmaceutical industry, ensuring scientific quality, regulatory compliance, and operational efficiency.
Comprehensive execution and monitoring of Phase I, II, and III clinical studies. Proven track record in the field. We work with international sponsors on multicenter trials.
Incorporation of new medical specialties in addition to oncology research.
Technical and human resources with consolidated experience in clinical research. Extensive patient referral network.
Our center is led by principal investigators with international experience, guaranteeing the highest ethical and scientific rigor in every clinical study.
Meet the team and track record →
We conduct Phase II, III, and IV clinical trials. We currently have open clinical studies with active recruitment for the following oncology indications:
Active studies in early and advanced stages, including hormone-dependent, HER2+, and Triple Negative subtypes.
Active studies in Non-Small Cell Lung Cancer (NSCLC), focused on targeted therapies and immunotherapy.
Research on innovative treatments for genitourinary tract cancers across various lines of treatment.
Clinical trials focused on gastrointestinal tumors in various treatment phases.
Targeted therapies for melanoma in early and advanced stages.
Please select your profile to direct your inquiry to the appropriate department for a prompt response. Our team is available to evaluate potential new studies and answer inquiries from patients and researchers.
Led by Dr. Guillermo Lerzo and Dr. Mónica Casalnuovo, the LC Investigación team maintains active participation in the most influential cooperative groups and scientific societies in global oncology.
This integration allows us to operate under international quality standards, ensuring technical excellence for the pharmaceutical industry and access to cutting-edge therapies for our patients.
Translational Research in Clinical Oncology
American Society of Clinical Oncology
European Society of Medical Oncology
Latin American Clinical Oncology Group
Breast International Group
European Society of Mastology
Argentine Association of Clinical Oncology
Argentine Group for Clinical Research in Oncology